295 related articles for article (PubMed ID: 26746614)
21. The effects of hyaluronic acid, epidermal growth factor, and mitomycin in an experimental model of acute traumatic tympanic membrane perforation.
Güneri EA; Tekin S; Yilmaz O; Ozkara E; Erdağ TK; Ikiz AO; Sarioğlu S; Güneri A
Otol Neurotol; 2003 May; 24(3):371-6. PubMed ID: 12806286
[TBL] [Abstract][Full Text] [Related]
22. Letter to the editor regarding: Rat model of chronic tympanic membrane perforation: Ventilation tube with mitomycin C and dexamethasone.
Lou ZC
Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():254-255. PubMed ID: 28693894
[No Abstract] [Full Text] [Related]
23. The impact of topical and systemic enoxaparin sodium use on traumatic tympanic membrane perforation and myringosclerosis.
Bilge A; Gunes A; Dagli M; Koybasioglu FF; Guvey A
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3035-41. PubMed ID: 26796878
[TBL] [Abstract][Full Text] [Related]
24. Extending Myringotomy Patency with Topical Everolimus in Rats.
Akbulut S; Altintas H; Berk D; Ozdemir N
Adv Clin Exp Med; 2016; 25(1):5-10. PubMed ID: 26935492
[TBL] [Abstract][Full Text] [Related]
25. Effect of topical use of mitomycin C and 5-fluorouracil on the closure time of myringotomies created by radiofrequency unit.
Baylancicek S; Sari M; Tutkun A
Acta Otolaryngol; 2009 Nov; 129(11):1212-6. PubMed ID: 19863313
[TBL] [Abstract][Full Text] [Related]
26. Direct application of keratinocyte growth factor, basic fibroblast growth factor and transforming growth factor-alpha during healing of tympanic membrane perforation in glucocorticoid-treated rats.
Ishimoto S; Ishibashi T; Bottaro DP; Kaga K
Acta Otolaryngol; 2002 Jul; 122(5):468-73. PubMed ID: 12206253
[TBL] [Abstract][Full Text] [Related]
27. The topical use of insulin accelerates the healing of traumatic tympanic membrane perforations.
Araujo MM; Murashima AA; Alves VM; Jamur MC; Hyppolito MA
Laryngoscope; 2016 Jan; 126(1):156-62. PubMed ID: 25891948
[TBL] [Abstract][Full Text] [Related]
28. Effect of Mitomycin C on bFGF, TGF-β1, KGF-1 Expressions after Myringotomy: An Animal Study.
Durak H; Atmaca S; Karayiğit MÖ; Yarım M
J Int Adv Otol; 2015 Dec; 11(3):188-91. PubMed ID: 26915147
[TBL] [Abstract][Full Text] [Related]
29. [An improved animal model for chronic perforation of the tympanic membrane].
Kaftan H; Hosemann W; Beule A; Junghans D
HNO; 2004 Aug; 52(8):714-9. PubMed ID: 15309252
[TBL] [Abstract][Full Text] [Related]
30. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat.
Spratley JE; Hellström SO; Mattsson CK; Pais-Clemente M
Ann Otol Rhinol Laryngol; 2001 Jun; 110(6):585-91. PubMed ID: 11407852
[TBL] [Abstract][Full Text] [Related]
31. Effects of ciprofloxacin/dexamethasone and ofloxacin on tympanic membrane perforation healing.
Buyten J; Kaufman G; Ryan M
Otol Neurotol; 2007 Oct; 28(7):887-90. PubMed ID: 17955604
[TBL] [Abstract][Full Text] [Related]
32. Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study.
Antonelli PJ; Winterstein AG; Schultz GS
Otol Neurotol; 2010 Apr; 31(3):519-23. PubMed ID: 20010446
[TBL] [Abstract][Full Text] [Related]
33. Acellular Collagen Scaffold With Basic Fibroblast Growth Factor for Repair of Traumatic Tympanic Membrane Perforation in a Rat Model.
Yao X; Teh BM; Li H; Hu Y; Huang J; Lv C; Bu S; Zheng M; Shen Y
Otolaryngol Head Neck Surg; 2021 Feb; 164(2):381-390. PubMed ID: 32662734
[TBL] [Abstract][Full Text] [Related]
34. Effect of ototopical ciprofloxacin-dexamethasone on myringotomy in a rat model.
Yazici A; Naiboglu B; Oysu C; Toros SZ; Noseri H; Karaca CT; Egeli E
Int J Pediatr Otorhinolaryngol; 2009 Feb; 73(2):301-5. PubMed ID: 19101045
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of MeroGel hyaluronic acid on tympanic membrane perforations.
Ozturk K; Yaman H; Cihat Avunduk M; Arbag H; Keles B; Uyar Y
Acta Otolaryngol; 2006 Dec; 126(11):1158-63. PubMed ID: 17050307
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of topical mitomycin C in myringotomy patency.
Jassir D; Buchman CA; Gomez-Marin O
Otolaryngol Head Neck Surg; 2001 Apr; 124(4):368-73. PubMed ID: 11283493
[TBL] [Abstract][Full Text] [Related]
37. Preventing myringotomy closure with topical mitomycin C in rats.
Estrem SA; Batra PS
Otolaryngol Head Neck Surg; 1999 Jun; 120(6):794-8. PubMed ID: 10352429
[TBL] [Abstract][Full Text] [Related]
38. Histopathology of tympanic membranes from patients with ventilation tubes.
Oktay MF; Tansuker HD; Fukushima H; Paparella MM; Schachern PA; Cureoglu S
Auris Nasus Larynx; 2018 Jun; 45(3):427-432. PubMed ID: 28774486
[TBL] [Abstract][Full Text] [Related]
39. After myringotomy, can topical Mesna application be an alternative method to ventilation tube application?
Karli R; Ilkaya F; Karli A; Gunbey E; Kucuk H; Guzel H; Ayhan E
Eur Arch Otorhinolaryngol; 2015 May; 272(5):1099-102. PubMed ID: 24510178
[TBL] [Abstract][Full Text] [Related]
40. Animal models of chronic tympanic membrane perforation: a 'time-out' to review evidence and standardize design.
Wang AY; Shen Y; Wang JT; Friedland PL; Atlas MD; Dilley RJ
Int J Pediatr Otorhinolaryngol; 2014 Dec; 78(12):2048-55. PubMed ID: 25455522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
